Evidence map›Paper›PMID 39409168›Full record

ArticleInternational journal of molecular sciences2024

Pleiotrophin Activates cMet- and mTORC1-Dependent Protein Synthesis through PTPRZ1-The Role of α

Eleni Mourkogianni, Katerina Karavasili, Athanasios Xanthopoulos, Michaela-Karina Enake, Lydia Menounou, Evangelia Papadimitriou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eleni MourkogianniLaboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, 26504 Patras, Greece.ORCID 0000-0001-9609-9997
Katerina KaravasiliLaboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, 26504 Patras, Greece.
Athanasios XanthopoulosLaboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, 26504 Patras, Greece.ORCID 0000-0003-2554-8630
Michaela-Karina EnakeLaboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, 26504 Patras, Greece.
Lydia MenounouLaboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, 26504 Patras, Greece.ORCID 0009-0009-6140-9153
Evangelia PapadimitriouLaboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, 26504 Patras, Greece.ORCID 0000-0001-6429-4325

Funding

State Scholarships Foundation 5000432
6 · The paper itself

Abstract

Pleiotrophin (PTN) is a secreted factor that regulates endothelial cell migration through protein tyrosine phosphatase receptor zeta 1 (PTPRZ1) and α

Indexed as

Carrier ProteinsCytokinesIntegrin alphaVbeta3Mechanistic Target of Rapamycin Complex 1Receptor-Like Protein Tyrosine Phosphatases, Class 5AnimalsCell MovementEndothelial CellsHumansHuman Umbilical Vein Endothelial CellsMicePhosphorylationProtein BiosynthesisSignal TransductionCarrier ProteinsCytokinesIntegrin alphaVbeta3Mechanistic Target of Rapamycin Complex 1pleiotrophinPTPRZ1 protein, humanReceptor-Like Protein Tyrosine Phosphatases, Class 5angiogenesisendothelial cellsintegrinmTORpleiotrophintyrosine kinasetyrosine phosphatase

Identifiers

PMID39409168
PMCPMC11477150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.